The first analysis of a multicentre paediatric supracondylar humerus fracture (SCHF) registry by fracture type

Mátyás Vajda1,2, Aba Lőrincz2, Lajos Szakó2

  • 1Saint George University Teaching Hospital of County-Fejér, 3 Seregélyesi Street, Székesfehérvár, H8000, Hungary.

Insights

Lower initial oxygen saturation indicates more severe pediatric supracondylar humerus fractures (SCHFs). Customized treatment is crucial, focusing on potential neurological issues and extended pin use for better outcomes in pediatric SCHF cases.

Area of Science:

  • Orthopedic Surgery
  • Pediatric Traumatology
  • Skeletal Research

Background:

  • Supracondylar humerus fractures (SCHFs) are common pediatric injuries with potential for severe complications.
  • Surgically treated SCHF cases present unique management challenges.

Purpose of the Study:

  • To analyze surgically treated pediatric SCHF cases from a national registry.
  • To identify factors correlating with fracture severity and treatment outcomes.

Main Methods:

  • Retrospective analysis of prospectively collected data from seven institutes.
  • Classification of 214 pediatric SCHFs into Gartland IIA, IIB, and III groups.
  • Statistical comparison of preoperative, operative, and postoperative data using Chi-Squared, Fisher's Exact, Kruskal-Wallis, and Dunn's tests.

Main Results:

  • Lower initial oxygen saturation correlated with higher fracture severity (p=0.0125).
  • Fracture complexity was directly proportional to operative time (p<0.01).
  • Less severe fractures required longer healing times before pin removal (p=0.0125).
  • No significant correlation found between BMI, injury mechanism, or initial radial pulse and fracture type.
  • Neurological complications showed a tendency in severe fractures, but overall complication rates did not differ significantly by type (p=0.0988).

Conclusions:

  • Initial oxygen saturation is a potential indicator of pediatric SCHF severity.
  • Attention to neurological complications and prolonged pin use is vital.
  • Tailored treatment strategies are essential for managing pediatric SCHFs effectively.
Abstract